The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys (Macaca fascicularis)

Blood Coagulation and Fibrinolysis

Volumn 8, Issue 5, 1997, Pages 274-283

  Mohri, M ^a   Gonda, Y ^a   Oka, M ^a   Aoki, Y ^a   Gomi, K ^a   Kiyota, T ^a   Sugihara, T ^a   Yamamoto, S ^a   Ishida, T ^a   Maruyama, I ^b  

^a ASAHI CHEMICAL INDUSTRY CO   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Anticoagulant; Crab eating monkey; Disseminated intravascular coalgulation; Protein C; Recombinant human soluble thrombomodulin

Indexed keywords

ANTITHROMBIN III; FIBRINOGEN; HEPARIN; PROTEIN C; RECOMBINANT PROTEIN; THROMBIN; THROMBOMODULIN; THROMBOPLASTIN;

ANIMAL MODEL; ANTICOAGULATION; ARTICLE; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE RESPONSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MACACA; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; RABBIT; RAT;

EID: 8544251325     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199707000-00003     Document Type: Article

References (25)

1. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-4746.
2. Dittman WA, Majerus PW. Structure and function of thrombomodulin. Blood 1990; 75: 329-336.
3. Esmon CT. Molecular events that control the protein C anticoagulant pathway. Thromb Haemostasis 1993; 70: 29-35.
4. Esmon CT. Protein C: biochemistry, physiology, and clinical implications. Blood 1983; 62: 1155-1158.
5. Marlar RA, Kleis AJ, Griffin JH. Mechanism of activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 1982; 59: 1067-1072.
6. Suzuki K, Kusumoto H, Deyashiki Y, et al. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J 1987; 6: 1891-1897.
7. Zushi M, Gomi K, Yamamoto S, Maruyama I, Hayashi T, Suzuki K. The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity. J Biol Chem 1989; 264: 10351-10353.
8. Zushi M, Gomi K, Honda G, et al. Aspartic acid 349 in the fourth epidermal growth factor-like structure of human thrombomodulin plays a role in its Camediated binding to protein C. J Biol Chem 1991; 266: 19886-19889.
9. Parkinson JF, Grinnell BW, Moore RE, Hoskins J, Vlahos CJ, Bang NU. Stable expression of a secretable deletion mutant of recombinant human thrombomodulin in mammalian cells. J Biol Chem 1990; 265: 12602-12610.
10. Nawa K, Sakano K, Fujiwara H, et al. Presence and function of chondroitin-4-sulfate on recombinant human soluble thrombomodulin. Biochem Biophys Res Commun 1990; 171: 729-737.
11. Nawa K, Itani T, Ono M, Sakano K, Marumoto Y, Iwamoto M. The glycosaminoglycan of recombinant human soluble thrombomodulin affects antithrombotic activity in rat model of tissue factor-induced disseminated intravascular coagulation. Thromb Haemostasis 1992; 67: 366-370.
12. Ye J, Esmon CT, Johnson AE. The chondroitin sulfate moiety of thrombomodulin binds a second molecule of thrombin. J Biol Chem 1993; 268: 2373-2379.
13. Suzuki K, Hayashi T, Nishioka J, et al. A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation. J Biol Chem 1989; 264: 4872-4876.
14. Ohishi R, Watanabe N, Aritomi M, et al. Evidence that the protein C activation pathway amplifies the inhibition of thrombin generation by recombinant human thrombomodulin in plasma. Thromb Haemostasis 1993; 70: 423-426.
15. Aritomi M, Watanabe N, Ohishi R, et al. Recombinant human soluble thrombomodulin delivers bounded thrombin to antithrombin III: thrombomodulin associ ates with free thrombin and is recycled to activate protein C. Thromb Haemostasis 1993; 70: 418-422.
16. Gomi K, Zushi M, Honda G, et al. Antithrombotic effect of recombinant human thrombomodulin on thrombin-induced thromboembolism in mice. Blood 1990; 75: 1396-1399.
17. Solis MM, Cook C, Cook J, et al. Intravenous recombinant soluble human thrombomodulin prevents venous thrombosis in a rat model. J Vasc Surg 1991; 14: 599-604.
18. Aoki Y, Takei R, Mohri M, et al. Antithrombotic effects of recombinant human soluble thrombomodulin (rhs-TM) on arterio-venous shunt thrombosis in rats. Am J Hematol 1994; 47: 162-166.
19. Gonda Y, Hirata S, Saitoh K, et al. Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats. Thromb Res 1993; 71: 325-335.
20. Mohri M, Oka M, Aoki Y, et al. Intravenous extended infusion of recombinant human soluble thrombomodulin prevented tissue factor-induced disseminated intravascular coagulation in rats. Am J Hematol 1994; 45: 298-303.
21. Aoki Y, Ohishi R, Takei R, et al. Effects of recombinant human soluble thrombomodulin (rhs-TM) on disseminated intravascular coagulation model in the rats with decreased plasma antithrombin III level. Thromb Haemostasis 1994; 71: 452-455.
22. Kogan AE, Makarov AN, Bobruskin ID, Strukova SM. Comparative study of protein C activators from the agkistrodon snake venoms. Thromb Res 1991; 62: 775-780.
23. Kimura M, Kurosawa-Ohsawa K, Takahashi M, Koyama M, Tanaka S, Matsuishi T. Purification of rabbit, rat and mouse protein C with the use of monoclonal antibody to human protein C, PC01. Thromb Res 1992; 67: 687-696.
24. Hanson SR, Griffin JH, Harker EA, Kelly AB, Esmon CT, Gruber A. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. J Clin Invest 1993; 92: 2003-2012.
25. Griffin JH. The thrombin paradox. Nature 1995; 378: 337-338.